+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age



Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age



American Journal of Epidemiology 156(6): 507-516



To gain insight into whether breast cancer tumors jointly classified by estrogen receptor (ER) and progesterone receptor (PR) status represent diseases with differing etiologies, data from a population-based case-control study of US women 20-44 years of age were analyzed. Cases included 1,556 women diagnosed between 1990 and 1992. Age- and geographic-frequency-matched controls included 1,397 women identified by random digit dialing. Heterogeneity between ER+PR+ and ER-PR- tumors was most pronounced in relation to age, race, and recreational exercise at 12-13 years of age. Multivariate-adjusted odds ratios for ER+PR+ tumors were 0.64 (95% confidence interval (CI): 0.47, 0.89) for 30-34 versus 40-44 years of age, 0.89 (95% CI: 0.63, 1.25) for Black versus White race, and 0.84 (95% CI: 0.68, 1.03) for exercise at 12-13 years of age above versus at or below the median. Corresponding odds ratios for ER-PR- tumors were 1.24 (95% CI: 0.86, 1.77), 1.51 (95% CI: 1.07, 2.14), and 1.15 (95% CI: 0.90, 1.48). Risk of ER-PR- cancer in relation to menstrual and reproductive (parity and lactation) characteristics, alcohol consumption, and family history of breast cancer was similar to that observed for ER+PR+ tumors. These findings only modestly support the hypothesis that hormonally related risk factors have differing relations with ER+PR+ versus ER-PR- tumors among younger women.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011306275

Download citation: RISBibTeXText

PMID: 12225998

DOI: 10.1093/aje/kwf065


Related references

Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detection and Prevention 29(5): 419-426, 2005

Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92(1): 37-45, 2001

Dietary fat and risk of breast cancer according to joint estrogen/progesterone receptor status. American Journal of Epidemiology 138(8): 591, 1993

Risk factors for postmenopausal breast cancer differ according to joint estrogen and progesterone receptor status. Proceedings of the American Association for Cancer Research Annual Meeting 34: 264, 1993

Association between organochlorines and breast cancer defined by joint estrogen receptor and progesterone receptor status. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1278, 2003

Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India. South Asian Journal of Cancer 7(1): 7, 2018

Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study. Cancer Epidemiology, Biomarkers & Prevention 4(4): 313-318, 1995

Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Research 8(4): R39-R39, 2006

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Research 8(4): R43, 2006

Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Research and Treatment 109(1): 77-90, 2007

Cigarette smoking and breast cancer risk in relation to joint estrogen and progesterone receptor status: a case-control study in Japan. Springerplus 3: 65, 2014

Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. Journal Of Nutrition8: 5, 938-945, 2008

Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. Journal of Nutrition 138(5): 938-945, 2008

Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women. The Journal of Nutrition 138(5): 938-945, 2008

Relation between receptor status and ultrastructure in breast cancer estrogen and progesterone receptor positive vs. estrogen and progesterone receptor negative. Pathology Research and Practice 181(4): 377-381, 1986